Pfizer and Flynn fined £70m for overcharging NHS for epilepsy drugs, competition watchdog
Drugmakers Pfizer and Flynn have been fined almost £70 million after they overcharged the NHS for a life-saving epilepsy drug, the competition watchdog has announced. The Competition and Markets Authority
Read More